Biopharma contributes to key global health discussions at WHA69
Find out here our take on the 69th World Health Assembly (WHA69) with some key relevant links included!
Read More
Pharmacovigilance of biotherapeutic medicines
A new study released in June 2016 identifying global case studies illustrating successes and challenges. A must read!
Read More
Our response to Zika virus
Check here about the R&D blueprint against Zika
Read More
Women’s Cancer Initiative in the Americas
Partnership to improve prevention of women’s cancers and quality of cancer registries in LAC reaches 1 year milestone
Read More
Latest News
2018-05-28 07:13:31
The R&D-based pharmaceutical industry supports the World Health Organization 5-year work plan and welcomes new era on health partnerships
28 May 2018, Geneva – IFPMA, the voice of the biopharmaceutical innovation and health progress around the world, made a ...
Read More2018-05-25 10:56:58
IFPMA Welcomes Set-Up of New African Medicines Agency
Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of ...
Read More2018-05-24 10:34:13
International Alliance of Patients’ Organizations joins Fight the Fakes as 36th partner
Thursday, 24th May, Miami – Fight the Fakes is proud to announce that the International ...
Read More2018-05-22 01:00:39
The pharmaceutical industry advocates for even greater collaboration as critical to future global health progress
Geneva, 22 May 2018 – IFPMA launches today “50 Years of Global Health Progress”. The ...
Read More2018-01-24 16:23:21
The African Global Health Leaders Fellowship launched to support the future of health in Africa
The African Global Health Leaders Fellowship launched to support the future of health in Africa ...
Read More2018-01-18 06:30:28
Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come
The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical ...
Read More2017-12-15 08:00:20
Greg Perry Joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical industry association, today announced the ...
Read More
Latest Statement
2018-05-25 13:23:33
IFPMA Statement: @WHA71 Item 12.7 – Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits
25 May 2018 Statement delivered by Paula Barbosa, IFPMA, Manager, Vaccines Policy Mr Chairman, IFPMA and its member companies ...
Read More2018-05-25 12:22:32
IFPMA Statement @WHA 71 agenda item 11.8 Preparation for a high-level meeting of the General Assembly on ending Tuberculosis
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More2018-05-24 15:44:48
IFPMA Statement @WHA 71 agenda item 11.7 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More2018-05-23 17:26:48
IFPMA Statement @WHA 71 agenda item 11.16 Global strategy and plan of action on public health, innovation and intellectual property
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More2018-05-23 17:19:39
IFPMA Statement @WHA 71 agenda item 11.5 Addressing the global shortage of, and access to, medicines and vaccines
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More2018-05-23 10:31:31
IFPMA Statement @WHA71 - Agenda item 11.1 Draft thirteenth general programme of work, 2019–2023
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More2018-03-23 00:00:47
IFPMA Statement: Biopharmaceutical industry marks World TB Day
Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...
Read More
mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig
Sadia Kaenzig - Communications Manager
Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.
mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol
Morgane De Pol - Communications and Public Affairs
Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.
Our Brouchure
2015 Edition
A shared commitment to global health
At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.
Our Logo
Full colour EPS format
Our Logo
Full colour PNG format
FULL Name LOGO
Full colour EPS format
FULL Name LOGO
Full colour PNG format
Hot Topic
Pharmacovigilance: Do your bit, play your part!
Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is
Read MoreInterview
IFPMA 2015 interview series 'Biodiversity, human health, and pharma'
A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to
Read MoreOur Blog
Latest Ebola response holds key to global health security
This blog piece has been first published in Africa Health Journal, July 2018 Latest Ebola response holds key to global health security Thomas Cueni discusses the important role of immunisation and the critical role of the pharmaceutical industry in combatting new threats such as with Ebola The recent deadly outbreak of Ebola virus disease (EVD) in the Democratic Republic of Congo (DRC) prompts fear, not...
Read More
Drugs companies are rising to the challenges of research into superbugs
This letter was first published on the Financial Times on 4th July 2018, in response to the article titled "Pharma sector failing to tackle superbugs, says O’Neill" (26th June 2018) I respectfully disagree with Jim O’Neill’s comments on pharmaceutical companies’ inaction on combating antimicrobial resistance (“ Pharma sector failing to tackle superbugs, says O’Neill”, June 26). As published in the AMR Industry Alliance’s progress...
Read More
Healthy mothers, healthy communities
This blog was first published on the Media Planet supplement for the Guardian on 27 June 2018 Last month, President Kagame told the World Health Assembly: “In Rwanda, a combination of community-based health insurance, community health workers, and good external partnerships led to the steepest reductions (a halving) in child and maternal mortality ever recorded”. But global progress is patchy. India, one of the...
Read MoreLatest Tweets
@IFPMA @IFPMA @IFPMA @IFPMA 